Haemonetics: A Revenue Rollercoaster in Q4 2025

The Earnings Snapshot

Haemonetics Corporation, a key player in the medical device sector, has just released its fourth quarter and fiscal 2025 results, and the numbers are more dramatic than a reality TV finale. For the quarter ending March 29, 2025, the company reported revenues of $331 million, reflecting a 4% decrease compared to the same period last year. This isn't quite the earnings surprise investors might have hoped for, especially when the EPS consensus was leaning toward a stable outlook.

Fiscal 2025: A Broader Perspective

For the full fiscal year, however, Haemonetics managed to pull a rabbit out of its hat with total revenues hitting $1.361 billion, showcasing a 4% increase year-over-year. The revenue forecast had been cautiously optimistic, but it seems the company?s ability to navigate market turbulence has paid off. While quarterly results might feel like a dip in the rollercoaster ride, the annual figures suggest a steady climb.

What Does This Mean?

So, what does this all mean for HAE and its peers? The modest quarterly decline could signal some turbulence in the market, potentially indicating that the company is experiencing challenges in maintaining momentum amidst competitive pressures. On the other hand, the annual growth suggests that Haemonetics is still a strong contender in the blood management space, where innovation and adaptability are key.

As we look ahead, investors will be keenly watching the upcoming quarters to see if the company can sustain its fiscal growth trend. Will they continue to improve their organic revenue growth, or will they grapple with the same headwinds that led to the quarterly dip? The upcoming earnings reports will be crucial in answering those questions.

Investor and Media Contacts

For those looking to dive deeper into the details, Haemonetics has provided a clear line to its investor relations team. Olga Guyette, Vice President of Investor Relations, and Josh Gitelson, Sr. Director of Global Communications, are on hand to address any inquiries. You can reach them at (781) 356-9763 or via email at olga.guyette@haemonetics.com and josh.gitelson@haemonetics.com.